CGON CIK: 1991792

CG Oncology, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25

Assets

(positive)
Change from FY23 to FY25
millions USD
FY23:
194
FY24:
754
FY25:
759
(positive)
Change from FY23 to FY25
millions USD
FY23:
5.18
FY24:
0.59
FY25:
32.1
Total assets
Change from FY23 to FY25
millions USD
FY23:
199
FY24:
755
FY25:
792

Liabilities & Equity

(negative)
Change from FY23 to FY25
millions USD
FY23:
14.3
FY24:
21.4
FY25:
30.8
(negative)
Change from FY23 to FY25
millions USD
FY23:
0.26
FY24:
0.05
FY25:
8.15
(positive)
Change from FY23 to FY25
millions USD
FY23:
−123
FY24:
733
FY25:
753
Total liabilities & equity
Change from FY24 to FY25
millions USD
FY23:
–
FY24:
755
FY25:
792

All amounts in millions USD Data source:SEC EDGAR